ABBOTT LABORATORIES — Director's Dealing 2009

Feb 7, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-04

Reporting Person: Landgraf John C (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-02-04	Common shares without par value	M	2200	$45.4488	Acquired	103675	Direct
2009-02-04	Common shares without par value	F	1754	$56.98	Disposed	101921	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-02-04	Option (right to buy)	$45.4488	M	2200	Disposed	2011-02-08	Common Shares (2200)	Direct
2009-02-04	Option (right to buy)	$56.98	A	1754	Acquired	2011-02-08	Common Shares (1754)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	15884	Indirect
Common shares without par value	30000	Indirect
Common shares without par value	1598	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 4, 2009.

F2: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees of the trust. The trust is revocable by his spouse.

F3: Includes shares acquired under the Abbott Laboratories Dividend Re-investment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16a-(11).

F4: Reporting person disclaims beneficial ownership of all securities held by his son.

F5: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.